您的位置：首页 > 产品中心 > NNC 55-0396 hydrate
产品别名
NNC 55-0396 hydrate
NNC55-0396
(1S,2S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride hydrate
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C30H40Cl2FN3O2 · xH2O |
| Molecular weight | 564.56 (anhydrous basis) |
| MDL number | MFCD12910446 |
| PubChem Substance ID【PubChem化学物质编号】 | 24278523 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | NNC-55-0396 is a T-type calcium channel antagonists. It is the structural analog of mibefradil. NNC-55-0396 has the ability to block cell proliferation and stimulate cell apoptosis in leukemia cell lines. Selective T-type calcium channel inhibitor |
| Features and Benefits【特点和优势】 | This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | solid |
| storage condition【储存条件】 | desiccated |
| color【颜色】 | white |
| solubility【溶解性】 | H2O: >10 mg/mL |
| originator【创始人】 | Roche |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | O.Cl.Cl.CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C5CC5 |
| InChI | 1S/C30H38FN3O2.2ClH.H2O/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27;;;/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33);2*1H;1H2/t28-,30-;;;/m0.../s1 |
| InChI key | ICVIUVXDXJUZRQ-SHQDEPIZSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| Personal Protective Equipment【个人防护装备】 | Eyeshields, Gloves, type N95 (US) |
